Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 134,945 $ 65,508
Accounts receivable (net of allowance of $250 and $0 at September 30, 2019 and December 31, 2018, respectively) 5,137 5,498
Short-term investments (certificates of deposit) 5,000 17,604
Inventory 941 678
Other receivables - related party 1,243 2,095
Prepaid expenses and other current assets 4,117 6,735
Restricted cash, current 14,929  
Current assets held for sale   13,089
Total current assets 166,312 111,207
Property and equipment, net 12,152 12,019
Operating lease right-of-use asset, net 21,876  
Restricted cash 1,145 16,074
Long-term investment, at fair value 11,193  
Intangible asset, net 7,731 1,417
Other assets 1,179 276
Total assets 221,588 140,993
Current liabilities    
Accounts payable and accrued expenses 28,512 34,067
Accounts payable and accrued expenses - related party   149
Interest payable 1,039 1,232
Interest payable - related party 89 97
Notes payable, short-term - related party (net of debt discount of $0 and $336 at September 30, 2019 and December 31, 2018, respectively) 15,472 9,164
Partner company convertible note, short-term, at fair value   9,914
Operating lease liabilities - short-term 1,741  
Derivative warrant liability   991
Total current liabilities 46,853 55,614
Notes payable, long-term (net of debt discount of $5,728 and $4,567 at September 30, 2019 and December 31, 2018, respectively) 68,542 60,425
Operating lease liabilities - long-term 24,168  
Other long-term liabilities 7,025 5,211
Total liabilities 146,588 121,250
Commitments and contingencies
Stockholders' equity    
Preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 1,026,111 and 1,000,000 shares issued and outstanding as of September 30, 2019 and December 31, 2018; liquidation value of $25.00 per share 1 1
Common stock, $.001 par value, 100,000,000 shares authorized, 70,335,534 and 57,845,447 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 70 58
Common stock issuable, 307,486 and 744,322 shares as of September 30, 2019 and December 31, 2018, respectively 500 659
Additional paid-in-capital 445,966 397,408
Accumulated deficit (420,742) (396,274)
Total stockholders' equity attributed to the Company 25,795 1,852
Non-controlling interests 49,205 17,891
Total stockholders' equity 75,000 19,743
Total liabilities and stockholders' equity $ 221,588 $ 140,993